Is the use of positron emission tomography/computed tomography (PET/CT) in investigating and/or assessing patients for diagnosis and/or staging of myeloma clinically and cost-effective?: in response to an enquiry from the Scottish Clinical Imaging Network PET/CT Group.
Healthcare Improvement Scotland.
Scottish Health Technologies Group.
Includes bibliographical references (pages 12-14).
System requirements: Adobe Reader required to view PDF document.
Description from online resource; title from PDF caption title (Healthcare Improvement Scotland, viewed 3 May, 2019)
Tumors
Tomography, Emission